Cue Biopharma (CUE) Other Gross PP&E Adjustments (2017 - 2025)
Cue Biopharma (CUE) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with -$5.2 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 17.21% to -$5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2025, up 17.21% year-over-year, with the annual reading at -$5.2 million for FY2025, 17.21% up from the prior year.
- Other Gross PP&E Adjustments hit -$5.2 million in Q4 2025 for Cue Biopharma, down from -$981000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.1 million in Q4 2022 to a low of -$8.1 million in Q4 2023.
- Historically, Other Gross PP&E Adjustments has averaged -$1.8 million across 5 years, with a median of -$1.2 million in 2023.
- Biggest YoY gain for Other Gross PP&E Adjustments was 211.35% in 2022; the steepest drop was 2875.48% in 2022.
- Year by year, Other Gross PP&E Adjustments stood at -$4.6 million in 2021, then surged by 211.35% to $5.1 million in 2022, then tumbled by 258.3% to -$8.1 million in 2023, then grew by 22.22% to -$6.3 million in 2024, then grew by 17.21% to -$5.2 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CUE at -$5.2 million in Q4 2025, -$981000.0 in Q3 2025, and -$790000.0 in Q2 2025.